Prognostic and predictive factors such as age, tumor size, nodal status, grading, Ki-67 proliferation index, angio-invasion, hormone receptor (HR) status, human epidermal growth factor receptor 2 (HER2) status are used in the clinical routine for prognosis of the patient and predicting benefit from therapy [7]. Here, ERBB2 is linked to neoplasm.